StockData

Bark vs PetMed Express

BARK and PETS side by side, both in miscellaneous retail. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BARK and PETS compare

Bark is the larger company, worth 3.6 times as much as PetMed Express ($82.2M against $23.1M).

PetMed Express grew revenue faster over the last twelve months (−19.2% versus −22.2% for Bark).

Bark keeps more of each dollar of sales as profit, with a net margin of −6.9% compared with −17.0% at PetMed Express.

Bark scores higher on the StockData Score (9 against 7 for PetMed Express), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBARKPETS
Size and price
Market cap$82.2M$23.1M
Share price$9.10$1.06
Change, 1 year−42.4%−59.2%
Change, 5 years−91.5%−96.4%
Beta (5Y)1.700.85
Employees501189
StockData Score
Total score9 (better)7
Valuation score33
Growth score1 (better)0
Performance score1 (better)0
Health score44
Dividend score00
Valuation
P/S0.2×0.1× (better)
P/B1.1× (better)1.4×
P/FCF176×–
FCF yield0.57% (better)−107%
Fair value$13.87$2.55
Margin of safety34.4%58.3% (better)
Growth
Revenue growth (TTM)−22.2%−19.2% (better)
Revenue growth, 5Y average0.84% (better)−10.0%
Profitability
Gross margin64.0% (better)27.8%
Operating margin−7.5% (better)−18.0%
Net margin−6.9% (better)−17.0%
FCF margin0.13% (better)−15.4%
Return on equity−30.8% (better)−90.8%
Return on invested capital−34.9% (better)−367%
Financial health
Debt / equity0.000.00
Interest coverage−59.0×–
Current ratio1.89 (better)0.60
Altman Z-score−0.971.00 (better)
Piotroski F-score4 (better)2
Dividends and buybacks
Dividend yield–0.00%
Years of dividend growth–0
Buyback yield2.8%–
Shareholder yield2.8% (better)0.00%
Ownership
Held by institutions23.3%21.4%
Held by insiders–32.7%
Insider net buying, 12 months−$70.3K$43.8K (better)
Short interest, % of float–5.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.